Benítez Catela, Lucía(Universitat Politècnica de València, 2014-11-14)
[ES] Análisis del gasto farmacéutico acerca de la enfermedad conocida como:
“enfermedad de Alzheimer”, en los pacientes de la Comunidad Valenciana y en
el departamento 9 de Salud.
Se empleará el sistema de agrupación ...
Vivas Consuelo, David José Juan; Guadalajara Olmeda, María Natividad; Barrachina Martínez, Isabel; Trillo-Mata, José-Luis; Usó-Talamantes, Ruth; De la Poza, Elena(Elsevier, 2011-11)
Background
The Valencian Autonomous Community (Spain) has implemented a scheme of purchasing services with the participation of public and private providers. Five districts are managed using public¿private partnership. ...
De la Poza, Elena; Guadalajara Olmeda, María Natividad; Jódar Sánchez, Lucas Antonio; Merello Giménez, Paloma(Elsevier, 2013-04)
Anxiolytics (AX) are the psychotropic drugs prescribed for the treatment of anxiety and
insomnia for 2–4 weeks, for longer periods of consumption (>1 month) may lead to
the development of tolerance or addiction. In fact, ...
Sancho Mestre, Carla; Vivas Consuelo, David José Juan; Alvis, Luis; Romero, Martin; Usó Talamantes, Ruth; Caballer Tarazona, Vicent(BioMed Central, 2016)
[EN] Background: The objective of the study is to estimate the frequency of multimorbidity in type 2 diabetes patients
classified by health statuses in a European region and to determine the impact on pharmaceutical ...
Vivas Consuelo, David José Juan; Usó Talamantes, Ruth; Guadalajara Olmeda, María Natividad; Trillo Mata, José Luis; Sancho Mestre, Carla; Buigues Pastor, Laia(BioMed Central, 2014-10-21)
Background
Pharmaceutical expenditure is undergoing very high growth, and accounts for 30% of overall healthcare expenditure in Spain. In this paper we present a prediction model for primary health care pharmaceutical ...